New Jersey S 234: Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2020-01-14)

State: New Jersey · Session: 219 · Bill: S 234

Subjects: PHARMACEUTIC

Sponsors: Gopal, Vin, Singleton, Troy, Greenstein, Linda R.

View New Jersey S 234 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.